Cargando…
Pilin Vaccination Stimulates Weak Antibody Responses and Provides No Protection in a C57Bl/6 Murine Model of Acute Clostridium difficile Infection
Clostridium difficile is the leading cause of nosocomial infections in the United States, adding billions of dollars per year to health care costs. A vaccine targeted against the bacterium would be extremely beneficial in decreasing the morbidity and mortality caused by C. difficile-associated disea...
Autores principales: | Maldarelli, Grace A, Matz, Hanover, Gao, Si, Chen, Kevin, Hamza, Therwa, Yfantis, Harris G, Feng, Hanping, Donnenberg, Michael S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927082/ https://www.ncbi.nlm.nih.gov/pubmed/27375958 http://dx.doi.org/10.4172/2157-7560.1000321 |
Ejemplares similares
-
Structure of the full-length Clostridium difficile toxin B
por: Chen, Peng, et al.
Publicado: (2019) -
The Enterotoxicity of Clostridium difficile Toxins
por: Sun, Xingmin, et al.
Publicado: (2010) -
Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota
por: Tam, John, et al.
Publicado: (2018) -
Identification of an Essential Region for Translocation of Clostridium difficile Toxin B
por: Chen, Shuyi, et al.
Publicado: (2016) -
Identification of Toxemia in Patients with Clostridium difficile Infection
por: Yu, Hua, et al.
Publicado: (2015)